|
Volumn 101, Issue 12, 2009, Pages 897-898
|
Re: Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: Randomized clinical trial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER INVASION;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
ENDOMETRIUM CARCINOMA;
HIGH RISK POPULATION;
HUMAN;
LETTER;
LYMPH NODE METASTASIS;
PELVIS LYMPHADENECTOMY;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
AORTA;
CARCINOMA;
DECISION MAKING;
ENDOMETRIUM TUMOR;
FEMALE;
LYMPHADENECTOMY;
METHODOLOGY;
NOTE;
PATHOLOGY;
PELVIS;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
AORTA;
CARCINOMA;
CHEMOTHERAPY, ADJUVANT;
DECISION MAKING;
ENDOMETRIAL NEOPLASMS;
FEMALE;
HUMANS;
LYMPH NODE EXCISION;
NEOPLASM STAGING;
PELVIS;
PROGNOSIS;
RADIOTHERAPY, ADJUVANT;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RESEARCH DESIGN;
TREATMENT OUTCOME;
|
EID: 67449152176
PISSN: 00278874
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djp124 Document Type: Letter |
Times cited : (38)
|
References (4)
|